• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Prognostic factors of follicular lymphoma treated with combination chemotherapy].

作者信息

Niitsu N, Umeda M

机构信息

First Department of Internal Medicine, Toho University of School of Medicine.

出版信息

Rinsho Ketsueki. 1997 Jun;38(6):496-504.

PMID:9248325
Abstract

This study investigated 72 patients (12.4%) with follicular lymphoma among 582 patients with non-Hodgkin's lymphoma admitted to our department. Treatment achieved complete remission (CR) in 83.3% of the follicular lymphoma patients, with an overall 5-year survival rate of 63.7%. The 5-year survival rate was 76.9% for the 60 patients who achieved CR, and this rate was significantly higher than that for patients who achieved only partial remission (PR) (p < 0.01). The 5-year survival rate was 40% with the CHOP regimen and 74.3% with the COP-BLAM regimen. The 3-year survival rate for biweekly COP-BLAM was 88.4%. The 5-year disease free survival rate for patients who achieved CR was 80.5%. The rate reached a plateau after 42 months, and the same survival was maintained for more than 10 years. These results suggest that intensive chemotherapy is effective even against follicular lymphoma. The 5-year survival rate for patients who achieved PR, suggesting the importance of the response to initial chemotherapy.

摘要

相似文献

1
[Prognostic factors of follicular lymphoma treated with combination chemotherapy].
Rinsho Ketsueki. 1997 Jun;38(6):496-504.
2
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
3
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Rinsho Ketsueki. 1993 Jul;34(7):829-34.
4
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.晚期霍奇金淋巴瘤化疗后部分缓解患者的受累野放疗。
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):19-30. doi: 10.1016/j.ijrobp.2006.08.041. Epub 2006 Nov 9.
5
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.以环磷酰胺、长春新碱、丙卡巴肼、泼尼松、阿霉素、博来霉素和长春花碱组成的联合化疗方案(C-MOPP/ABV)作为晚期霍奇金病患者的一线治疗方案。
Cancer. 2000 May 1;88(9):2142-8.
6
[Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].采用ProMACE-CytaBOM方案治疗侵袭性非霍奇金淋巴瘤
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):345-8.
7
[Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].[阿霉素、环磷酰胺、长春新碱、泼尼松龙联合化疗(VEPA)治疗非霍奇金淋巴瘤,特别提及表面表型与反应及生存的相关性]
Gan To Kagaku Ryoho. 1988 Jul;15(7):2057-63.
8
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.I-II期惰性非霍奇金淋巴瘤综合治疗前瞻性研究的长期随访
J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111.
9
[Treatment of primary mediastinal large B-cell lymphomas].[原发性纵隔大B细胞淋巴瘤的治疗]
Orv Hetil. 2004 Dec 12;145(50):2531-7.
10
[Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
Gan To Kagaku Ryoho. 1987 Sep;14(9):2692-6.

引用本文的文献

1
Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.利妥昔单抗时代日本晚期滤泡性淋巴瘤患者生存时间、组织学转化及继发性恶性肿瘤的长期调查:北海道血液学研究组
Int J Hematol. 2014 Sep;100(3):281-9. doi: 10.1007/s12185-014-1629-4. Epub 2014 Jul 23.
2
Anthracycline-containing regimens for treatment of follicular lymphoma in adults.含蒽环类药物的方案用于治疗成人滤泡性淋巴瘤。
Cochrane Database Syst Rev. 2013 Jul 7;2013(7):CD008909. doi: 10.1002/14651858.CD008909.pub2.